Chockalingam Palaniappan
2021
In 2021, Chockalingam Palaniappan earned a total compensation of $726K as Chief Innovation Officer at Ortho Clinical Diagnostics Holdings plc.
Compensation breakdown
| Non-Equity Incentive Plan | $236,958 |
|---|---|
| Salary | $459,087 |
| Other | $30,000 |
| Total | $726,046 |
Palaniappan received $459.1K in salary, accounting for 63% of the total pay in 2021.
Palaniappan also received $237K in non-equity incentive plan and $30K in other compensation.
Rankings
In 2021, Chockalingam Palaniappan's compensation ranked 9,779th out of 12,406 executives tracked by ExecPay. In other words, Palaniappan earned more than 21.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,779 out of 12,406 | 21st |
Division Manufacturing | 4,329 out of 5,492 | 21st |
Major group Chemicals And Allied Products | 1,924 out of 2,368 | 19th |
Industry group Drugs | 1,708 out of 2,089 | 18th |
Industry In Vitro and In Vivo Diagnostic Substances | 44 out of 61 | 28th |
Source: SEC filing on May 2, 2022.
Palaniappan's colleagues
We found four more compensation records of executives who worked with Chockalingam Palaniappan at Ortho Clinical Diagnostics Holdings plc in 2021.
2021
Christopher Smith
Ortho Clinical Diagnostics Holdings plc
Chief Executive Officer
2021
Michael Iskra
Ortho Clinical Diagnostics Holdings plc
Executive Vice President, Strategy & Commercial Excellence
2021
Michael Schlesinger
Ortho Clinical Diagnostics Holdings plc
General Counsel
2021
Joseph Busky
Ortho Clinical Diagnostics Holdings plc